Loading
Insider filings for Annidis Corporation are scarce in the SEDI feed, the latest one published on 8 June 2016. This page will fill in as new trades are disclosed. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
3 of 3 declarations
Annidis Corporation is a publicly traded company on the Toronto Stock Exchange, specializing in the development of medical diagnostic technologies. It focuses on improving eye care through innovative solutions.